199 related articles for article (PubMed ID: 1447658)
1. Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease.
Lin CY; Lin CC; Hwang B; Chiang B
J Pediatr; 1992 Dec; 121(6):924-6. PubMed ID: 1447658
[TBL] [Abstract][Full Text] [Related]
2. Cytokines predict coronary aneurysm formation in Kawasaki disease patients.
Lin CY; Lin CC; Hwang B; Chiang BN
Eur J Pediatr; 1993 Apr; 152(4):309-12. PubMed ID: 8482278
[TBL] [Abstract][Full Text] [Related]
3. Correlates of coronary artery aneurysm formation in patients with Kawasaki disease.
Daniels SR; Specker B; Capannari TE; Schwartz DC; Burke MJ; Kaplan S
Am J Dis Child; 1987 Feb; 141(2):205-7. PubMed ID: 3812389
[TBL] [Abstract][Full Text] [Related]
4. Acute pericardial effusion representing the TNF-α-mediated severe inflammation but not the coronary artery outcome of Kawasaki disease.
Okada S; Hasegawa S; Suzuki Y; Matsubara T; Shimomura M; Okuda M; Ichiyama T; Ohga S
Scand J Rheumatol; 2015 May; 44(3):247-52. PubMed ID: 25351965
[TBL] [Abstract][Full Text] [Related]
5. The serum concentration of soluble interleukin-2 receptor in patients with Kawasaki disease.
Teraura H; Kotani K; Minami T; Takeshima T; Shimooki O; Kajii E
Ann Clin Biochem; 2017 Mar; 54(2):209-213. PubMed ID: 28081636
[TBL] [Abstract][Full Text] [Related]
6. Impairment of angiogenic activity in the serum from patients with coronary aneurysms due to Kawasaki disease.
Higashi K; Terai M; Hamada H; Honda T; Kanazawa M; Kohno Y
Circ J; 2007 Jul; 71(7):1052-9. PubMed ID: 17587710
[TBL] [Abstract][Full Text] [Related]
7. Atypical Kawasaki disease: coronary aneurysms and thrombocytopenia.
Kinney JB; Albano E; Krober MS; Stevenson JG
South Med J; 1992 Jan; 85(1):40-2. PubMed ID: 1734535
[TBL] [Abstract][Full Text] [Related]
8. Elevated levels of high-sensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease: association between inflammation and late coronary sequelae in Kawasaki disease.
Mitani Y; Sawada H; Hayakawa H; Aoki K; Ohashi H; Matsumura M; Kuroe K; Shimpo H; Nakano M; Komada Y
Circulation; 2005 Jan; 111(1):38-43. PubMed ID: 15611368
[TBL] [Abstract][Full Text] [Related]
9. [Is the determination of procalcitonin useful in Kawasaki disease?].
Caballero Mora FJ; Alvarez-Coca González J; Alonso Martín B; Martínez Pérez J
An Pediatr (Barc); 2009 Oct; 71(4):371-2. PubMed ID: 19726253
[No Abstract] [Full Text] [Related]
10. Serum-soluble interleukin-2 receptor levels in Kawasaki disease.
Lang BA; Silverman ED; Laxer RM; Rose V; Nelson DL; Rubin LA
J Pediatr; 1990 Apr; 116(4):592-6. PubMed ID: 2319407
[No Abstract] [Full Text] [Related]
11. Regression of coronary aneurysms in patients with Kawasaki syndrome.
Takahashi M; Mason W; Lewis AB
Circulation; 1987 Feb; 75(2):387-94. PubMed ID: 3802442
[TBL] [Abstract][Full Text] [Related]
12. The changes of interleukin-2, tumour necrotic factor and gamma-interferon production among patients with Kawasaki disease.
Lin CY; Lin CC; Hwang B; Chiang BN
Eur J Pediatr; 1991 Jan; 150(3):179-82. PubMed ID: 1904353
[TBL] [Abstract][Full Text] [Related]
13. Giant Coronary Aneurysms in a one-month-old Infant with Kawasaki Disease.
Kim JH; Kim M; Oh JH; Lee JY; Lee KY; Koh DK
Indian J Pediatr; 2017 Feb; 84(2):162-163. PubMed ID: 27641973
[No Abstract] [Full Text] [Related]
14. Decreased serum Annexin A1 levels in Kawasaki disease with coronary artery aneurysm.
Weng H; Peng Y; Pei Q; Jing F; Yang M; Yi Q
Pediatr Res; 2021 Feb; 89(3):569-573. PubMed ID: 32316027
[TBL] [Abstract][Full Text] [Related]
15. Infliximab as a novel therapy for refractory Kawasaki disease.
Weiss JE; Eberhard BA; Chowdhury D; Gottlieb BS
J Rheumatol; 2004 Apr; 31(4):808-10. PubMed ID: 15088313
[TBL] [Abstract][Full Text] [Related]
16. Thrombocytopenia: a complication of Kawasaki disease.
Hara T; Mizuno Y; Akeda H; Fukushige J; Ueda K; Aoki T; Sunagawa H; Honda S; Hijii T; Yamaguchi Y
Eur J Pediatr; 1988 Jan; 147(1):51-3. PubMed ID: 3338478
[TBL] [Abstract][Full Text] [Related]
17. Clinical aspects of 100 patients with Kawasaki disease.
Tizard EJ; Suzuki A; Levin M; Dillon MJ
Arch Dis Child; 1991 Feb; 66(2):185-8. PubMed ID: 1900405
[TBL] [Abstract][Full Text] [Related]
18. Kawasaki syndrome: still a fascinating enigma.
Barron KS; Murphy DJ
Hosp Pract (Off Ed); 1989 Oct; 24(10):51-60. PubMed ID: 2507564
[TBL] [Abstract][Full Text] [Related]
19. Coronary artery involvement in Kawasaki syndrome in Manhattan, New York: risk factors and role of aspirin.
Ichida F; Fatica NS; Engle MA; O'Loughlin JE; Klein AA; Snyder MS; Ehlers KH; Levin AR
Pediatrics; 1987 Dec; 80(6):828-35. PubMed ID: 3684392
[TBL] [Abstract][Full Text] [Related]
20. Prediction of patients with a high risk of coronary artery aneurysm in Kawasaki disease: indication for immunoglobulin therapy.
Nakano H
Prog Clin Biol Res; 1987; 250():287-97. PubMed ID: 3423043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
